Adipotide

Also known as: FTPP, Prohibitin-targeting peptide

MetabolicPRECLINICAL

Clinical Status

Preclinical — animal studies showed fat reduction but significant toxicity.

Mechanism of Action

Contains a targeting sequence that binds to prohibitin on blood vessels supplying white adipose tissue, fused to a pro-apoptotic sequence. Induces apoptosis in the vasculature feeding fat tissue, causing fat cell death.

Dosing Defaults

Dose

0.5-1 mg/kg weekly

Frequency

1-2x weekly

Administration

Subcutaneous injection

Timing

Morning

Food

with or without

Duration

4 weeks maximum

Dose range: 0.5-1 mg/kg per week

Timing is less critical; consistency matters.

Side Effects

•Kidney damage (significant concern)
•Dehydration
•Fatigue
•Injection site reactions
•Potential organ damage

Contraindications & Warnings

⚠Kidney disease
⚠Dehydration

•Not medical advice
•Significant nephrotoxicity observed in animal studies

Compare

Compare Adipotide with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Adipotide dose.

Open Calculator

Related Metabolic Peptides

5-Amino-1MQ

PRECLINICAL

Metabolic

NNMT inhibitor that boosts NAD+ for fat metabolism. Does not affect appetite.

AICAR

PHASE 2

Metabolic

AMPK activator known as an "exercise mimetic." Enhances endurance capacity.

Tesofensine

PHASE 3

Metabolic

Triple monoamine reuptake inhibitor for appetite suppression and thermogenesis.

Setmelanotide

FDA APPROVED

Metabolic

MC4R agonist for rare genetic obesity. FDA-approved for specific mutations.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.